I agree we need more dissenting but informed positions. It is laughable to just come on a biotech stock forum say the words fundamental or value investing and be rewarded with praise. A dissenting opinion should talk about scalability, competitor milestones, potential trial results and liquidity. I cringe every time I see someone praise posters who just say cash flow. Look at the posts from OP, we need his evil twin.
when someone comes on that board with that view let’s give them the credit they deserve.
Ann: MSB and Lonza Enter GVHD Commercial Manufacturing Agreement, page-99
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |